| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |